Camila 28 Day Shortage: What Providers and Prescribers Need to Know in 2026

Provider Briefing: Camila 28 Day Availability in 2026

If your patients have been calling about difficulty filling their Camila 28 Day prescriptions, you're not alone. Progestin-only oral contraceptive availability has been inconsistent across pharmacies nationwide, creating prescribing challenges and patient anxiety. This briefing covers the current state of Camila 28 Day availability, its implications for clinical practice, and practical tools to help your patients maintain uninterrupted contraceptive coverage.

Background: Camila 28 Day

Camila 28 Day is a progestin-only oral contraceptive (POP) containing Norethindrone 0.35 mg, manufactured by Mayne Pharma. It is indicated for the prevention of pregnancy and is a critical option for patients who have contraindications to estrogen-containing contraceptives, including:

• Migraine with aura
• History of venous thromboembolism (VTE)
• Uncontrolled hypertension
• Current breastfeeding (particularly in the early postpartum period)
• Cardiovascular disease or significant risk factors
• Smoking in women over age 35

Norethindrone 0.35 mg works primarily by thickening cervical mucus and suppressing ovulation in approximately 50% of cycles. It requires strict adherence — patients must take it within the same 3-hour window daily, with backup contraception needed for 48 hours if a dose is delayed more than 3 hours.

Shortage Timeline and Current Status

2023–2024: Supply Chain Disruptions

Beginning in 2023, broader pharmaceutical supply chain pressures affected oral contraceptive availability across multiple manufacturers. While Norethindrone 0.35 mg was not placed on the FDA Drug Shortage list, individual brand availability — including Camila — became unpredictable at the pharmacy level.

2025: Stabilization With Ongoing Gaps

Supply chains partially stabilized through 2025, but pharmacy-level availability remained inconsistent. Distributor contract changes caused some chains to rotate between Norethindrone brands (Camila, Errin, Heather, Jencycla), leading to patient confusion and frequent calls to prescribers' offices.

2026: Current Picture

As of early 2026, Camila 28 Day is not listed on the FDA Drug Shortage database. Norethindrone 0.35 mg remains available from multiple generic manufacturers. However, the specific Camila brand may be intermittently unavailable at certain pharmacies depending on their distributor agreements. This is a distribution issue rather than a manufacturing shortage.

Prescribing Implications

Generic Substitution

All Norethindrone 0.35 mg products are AB-rated generic equivalents. Pharmacists can substitute Errin, Heather, Jencycla, Jolivette, Nora-BE, Norlyda, Sharobel, Deblitane, or Incassia for Camila without a new prescription in most states, provided the prescription is written for Norethindrone or does not specify "dispense as written" (DAW).

Clinical recommendation: Consider writing prescriptions for "Norethindrone 0.35 mg" rather than the brand name "Camila" to give pharmacists maximum flexibility in filling from available stock.

Patient Education on Brand Switching

Patients may express concern about switching brands. Key counseling points:

• All Norethindrone 0.35 mg products contain the same active ingredient at the same dose
• Inactive ingredients (fillers, dyes) differ but rarely cause clinical issues
• Effectiveness is identical across all AB-rated products
• No need for backup contraception when switching between Norethindrone brands

Timing Sensitivity Counseling

When patients experience gaps in supply, reinforce the critical importance of the 3-hour dosing window. Any delay beyond 3 hours requires 48 hours of backup contraception. Patients experiencing frequent supply disruptions may benefit from a switch to a method with less timing sensitivity.

Availability Picture: Where Patients Can Find Norethindrone

Recommend these resources to patients struggling to find their medication:

• Medfinder for Providers: A real-time pharmacy stock checker that helps patients (and your staff) locate Norethindrone 0.35 mg at nearby pharmacies. Consider recommending this to patients or using it in your practice workflow.
• Independent pharmacies: Often have access to multiple distributors and can special-order specific brands within 1–2 business days.
• Telehealth platforms: Nurx, Pandia Health, and similar services can prescribe and deliver Norethindrone by mail, providing an alternative for patients in areas with limited pharmacy stock.

Cost and Access Considerations

Under the ACA contraceptive coverage mandate, most insured patients should receive Norethindrone at $0 cost-sharing. For uninsured patients:

• Cash price: $20–$55 per 28-day supply for Camila brand
• Generic with discount card: $8–$15 via GoodRx, SingleCare, or RxSaver
• Title X clinics and Planned Parenthood: Often provide Norethindrone at no cost or on a sliding fee scale
• 340B pharmacies: Eligible patients can access Norethindrone at significantly reduced prices through 340B-enrolled entities

No specific manufacturer patient assistance program exists for Camila from Mayne Pharma, but generic availability makes this less of a barrier.

Tools and Resources for Your Practice

Streamlining the Prescription Process

1. Write generic: Prescribe "Norethindrone 0.35 mg" rather than brand Camila to allow pharmacy substitution
2. Avoid DAW: Unless clinically necessary, avoid "dispense as written" codes that restrict brand substitution
3. Prescribe 90-day supplies: When insurance allows, 90-day supplies reduce the frequency of refill-related availability issues
4. Pre-authorize alternatives: Document in the patient's chart that substitution to any AB-rated Norethindrone 0.35 mg product is acceptable

When to Consider a Method Change

For patients with recurring supply issues, consider transitioning to:

• Slynd (Drospirenone 4 mg): Progestin-only pill with 24-hour missed-dose window and more reliable ovulation suppression. Higher cost but increasingly insured.
• Depo-Provera: Progestin-only injection every 13 weeks — eliminates daily adherence and pharmacy supply concerns.
• Hormonal IUD (Mirena, Liletta, Kyleena): Long-acting, reversible, progestin-only. 3–8 year duration eliminates ongoing pharmacy interactions entirely.
• Nexplanon: Subdermal implant lasting 3 years. Progestin-only, highly effective.

For a patient-facing version of these alternatives, direct patients to: Alternatives to Camila 28 Day.

Looking Ahead

The progestin-only contraceptive landscape continues to evolve. The availability of Opill (Norgestrel 0.075 mg) as the first OTC oral contraceptive provides another option for patients who face prescribing or pharmacy barriers. While it uses a different progestin and dosing schedule than Norethindrone, it may be appropriate for some patients.

Supply chain resilience for generic oral contraceptives is expected to continue improving through 2026–2027 as manufacturers expand production capacity. In the meantime, proactive prescribing strategies and patient education remain the most effective tools for maintaining contraceptive continuity.

Final Thoughts

Camila 28 Day availability issues in 2026 are primarily a distribution challenge, not a manufacturing shortage. By writing prescriptions generically, educating patients about brand equivalence, and leveraging tools like Medfinder for Providers, you can minimize disruptions to your patients' contraceptive care.

For patient-facing resources to share with your practice, see:

• Camila 28 Day Shortage Update: What Patients Need to Know
• How to Find Camila 28 Day in Stock Near You
• What Is Camila 28 Day? Uses, Dosage, and What You Need to Know